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Abstract
Background: Rates of perinatal depression (antenatal and postnatal depression) in South Asia are among the
highest in the world. The delivery of effective psychological treatments for perinatal depression through existing
health systems is a challenge due to a lack of human resources.
This paper reports on a trial protocol that aims to evaluate the effectiveness and cost-effectiveness of the Thinking
Healthy Programme delivered by peers (Thinking Healthy Programme Peer-delivered; THPP), for women with
moderate to severe perinatal depression in rural and urban settings in Pakistan and India.
Methods/Design: THPP is evaluated with two randomised controlled trials: a cluster trial in Rawalpindi, Pakistan,
and an individually randomised trial in Goa, India. Trial participants are pregnant women who are registered with
the lady health workers in the study area in Pakistan and pregnant women attending outpatient antenatal clinics in
India. They will be screened using the patient health questionnaire-9 (PHQ-9) for depression symptoms and will be
eligible if their PHQ-9 is equal to or greater than 10 (PHQ-9 ≥ 10). The sample size will be 560 and 280 women in
Pakistan and India, respectively. Women in the intervention arm (THPP) will be offered ten individual and four
group sessions (Pakistan) or 6–14 individual sessions (India) delivered by a peer (defined as a mother from the same
community who is trained and supervised in delivering the intervention). Women in the control arm (enhanced
usual care) will receive health care as usual, enhanced by providing the gynaecologist or primary-health facilities
with adapted WHO mhGAP guidelines for depression treatment, and providing the woman with her diagnosis and
information on how to seek help for herself. The primary outcomes are remission and severity of depression
symptoms at the 6-month postnatal follow-up. Secondary outcomes include remission and severity of depression
symptoms at the 3-month postnatal follow-up, functional disability, perceived social support, breastfeeding rates,
infant height and weight, and costs of health care at the 3- and 6-month postnatal follow-ups. The primary analysis
will be intention-to-treat.
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Discussion: The trials have the potential to strengthen the evidence on the effectiveness and cost-effectiveness of an
evidence-based psychological treatment recommended by the World Health Organisation and delivered by peers for
perinatal depression. The trials have the unique opportunity to overcome the shortage of human resources in global
mental health and may advance our understanding about the use of peers who work in partnership with the existing
health systems in low-resource settings.
Trial registration: Pakistan Trial: ClinicalTrials.gov Identifier: NCT02111915 (9 April 2014)
India Trial: ClinicalTrials.gov Identifier: NCT02104232 (1 April 2014)
Keywords: Thinking Healthy Programme, Psychological treatment, Peers, Non-mental health professionals, Perinatal
depression, Task-shifting, Randomised trials, Low and middle income countries
Background
Depression is one of the leading burdens of disease glo-
bally and there is a large treatment gap, especially in low-
and middle-income countries (LMICs) [1, 2]. In South
Asia, the prevalence of common mental disorders is re-
ported to be among the highest in the world [3–6] ranging
from 18 and 30 % in urban areas [4, 7, 8] to 28–36 % in
rural areas [9–11]. In addition to constituting a burden to
women’s health, disability, functioning and mortality, par-
ticularly through suicide [12, 13], perinatal depression is
associated with negative child outcomes including infant
under-nutrition and stunting, and has been declared a glo-
bal threat to child health and development [14–16]. Peri-
natal depression is defined as having a depressive episode
either during pregnancy or during the one-year postnatal
period [17, 18].
Systematic reviews in high-income countries provide
robust evidence that perinatal depression can be man-
aged effectively with psychological treatments [19, 20]. A
recent systematic review for LMICs showed the burden
of perinatal depression could be reduced through mental
health interventions delivered by non-specialists [21].
Apart from reducing perinatal depression, these psycho-
logical treatments have shown to improve child health
outcomes like increased vaccination coverage and re-
duced diarrheal episodes. Such interventions have been
shown to improve child health outcomes [22]. However,
integrating and scaling up such interventions within the
existing heath systems with them delivered by commu-
nity health workers (CHWs) in LMICs is challenging be-
cause CHWs are already overburdened and are a finite
human resource, and there is limited evidence of the
cost-effectiveness of such interventions [2, 23, 24].
The South Asian Hub for Advocacy, Research and
Education for mental health (SHARE) was established by
a grant funded by the US National Institute of Mental
Health (NIMH) to address these challenges. SHARE
aims to adapt an established evidence-based interven-
tion, the Thinking Healthy Programme (THP) originally
developed and evaluated in Pakistan [22, 25]. THP has
recently been adopted by the World Health Organisation
(WHO) for global implementation (http://www.who.int/
mental_health/maternal-child/thinking_healthy/en/) [26],
and has now been adapted for delivery by peers (called the
Thinking Healthy Programme Peer-Delivered or THPP)
in India and Pakistan, through extensive formative re-
search [27]. The peers who deliver the intervention are
women with children living in the same community as the
participants, and who work in partnership with estab-
lished CHWs. In this paper, we describe the protocol for
two concurrent randomised controlled trials being con-
ducted in India and Pakistan, which aim to evaluate the
effectiveness and cost-effectiveness of the THPP on mater-
nal and child outcomes. Both trials have identical inter-
ventions and outcomes with some differences, which are
highlighted by referring to them as SHARE Pakistan and
SHARE India.
Objectives and hypothesis
The objectives of the trials are to evaluate the effectiveness
and cost-effectiveness of THPP for women with moderate
to severe perinatal depression in Rawalpindi, Pakistan, and
Goa, India. The primary hypothesis is that the THPP
intervention provided together with enhanced usual care
(EUC) will be superior to EUC alone in increasing the
proportion with remission from perinatal depression and
reducing perinatal depressive symptoms at the 6-month
postnatal follow-up. We will test secondary hypotheses
that the THPP intervention is associated with a range of
maternal and child outcomes (Tables 1 and 2).
Methods/design
Trial settings
The trials will be conducted in rural and urban settings
(the rural sub-district of Kallar Syedan, Rawalpindi,
Pakistan, and peri-urban Goa, India, respectively). Table 3
provides information about the SHARE Pakistan and
SHARE India study settings.
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Design
SHARE Pakistan
In Pakistan, the trial will be a stratified cluster randomised
controlled trial, with 40 village clusters allocated in a 1:1
ratio to the intervention and control arms. A village clus-
ter, with a population of 2400–3600 with two or three ad-
jacent catchment areas for lady health workers (LHWs),
will form the unit of randomisation, and participants will
be recruited from the community. The reason for choos-
ing a village cluster as the unit of randomisation was to
minimise contamination between trial participants.
SHARE India
In India, the trial will be an individual randomised con-
trolled trial in which women attending the outpatient
antenatal clinics from North Goa District Hospital and
Goa Medical College Hospital will be allocated in a 1:1
ratio to the intervention and control arms. Since women
attending the two hospitals come from selected areas
across North Goa, the chances of contamination are less,
allowing for individual randomisation. Randomisation
will be stratified as rural or urban, based on the individ-
ual’s area of residence.
Participants and procedures
The trial flow charts (Figs. 1 and 2) show the process of
recruitment and follow-up of participants in both trials.
Identification of eligible women
In Pakistan, each village cluster is covered by two or
three government-employed CHWs called LHWs. The
primary role of the LHWs is to provide health education
and basic maternal and child health care through
monthly home visits. Each LHW is responsible for about
150 households and keeps a register of every new preg-
nancy in her catchment area. All pregnant women living
Table 1 Primary and secondary outcomes of the trials
Source of data (see Table 2 for details of each measure)
Outcomes Measure End point
Remission at 6 months (PHQ scores <10 and < 5) &
Depression severity (PHQ scores)
Patient health questionnaire (PHQ-9) 3- and 6-month postnatal follow-up
Disability scores WHO disability assessment schedule (WHO-DAS) 3- and 6-month postnatal follow-up
Perceived social support of the mother Multidimensional scale of perceived social support 3- and 6-month postnatal follow-up
Rates of exclusive breastfeeding Maternal 24-hour recall using the WHO definition
of exclusive breastfeeding
3- and 6-month postnatal follow-up
Infant nutritional status Digital scales for weight and tape measure for
height (height mats)
3- and 6-month postnatal follow-up
Costs of illness Client service receipt inventory 3- and 6-month postnatal follow-up
Serious adverse events (SAEs) SAE form 3- and 6-month postnatal follow-up
Table 2 Pakistan and India trial outcome assessments
Instrument Description Outcome Contextual validity
PHQ-9 Nine-item questionnaire assessment
of depressive symptoms assessed on
a scale of 0 to 3
Prevalence of moderate–severe
depression; mean total score
Validated in primary care [29]
WHO disability assessment
schedule
12-item questionnaire for measuring
functional impairment over the last
30 days. In addition, two items assess
the number of days the person was
unable to work in these 30 days
Total disability score; quality adjusted
life years; number of days out of work
Validated for international use [36]
Client service receipt
inventory
Questionnaire to collect data on the
utilisation and costs of health care
and lost productivity (including that
of caregivers)
Costs of illness (direct and indirect) Previously used in the study settings,
an adapted version will be used based
on an international study on perinatal
depression [37]
Multidimensional scale of
perceived social support
12-item questionnaire to measure
perceived social support of the mother
Perceived social support of the mother;
total score
Used in the study settings [22]
Exclusive breastfeeding 24-hour maternal recall using the WHO
definition of exclusive breastfeeding
Proportion of infants exclusively
breastfed
Used in the study settings [38, 39]
Height and weight of
infant
Digital scales for weight and tape
measure for height (height mats)
Height in centimetres and weight in
grams
Extensively used in the study settings
[22, 40]
Serious adverse events
(SAEs)
Specifically designed questionnaire
for the trials
Proportion of SAEs Specifically designed for the trials
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in the study area who are on the registers of the LHWs,
will be checked for eligibility. The SHARE Pakistan trial
has obtained a letter of permission signed by the District
Health Department (Province of Punjab, Pakistan), under
which the health system functions in all the village clus-
ters, to access the LHW registers. In India, all pregnant
women registering at the outpatient antenatal clinics of
the hospitals will be checked for eligibility.
All potentially eligible women identified from the regis-
ters will be invited by trained research assessment teams
to be screened for depression using the patient health
questionnaire (PHQ-9). The questionnaire scores the nine
symptom-based criteria for depression in the Diagnostic
and Statistical Manual of Mental Disorders, fourth edition
(DSM-IV) on a four-point Likert scale from not having
the symptom at all, to having it nearly every day, over the
last 2 weeks. The score for each item is summed to arrive
at a total score. The cut-off point of 10 is selected as the
most accurate value for the detection of depression [28]
and has a high positive predictive value for the diagnosis
of depressive disorder [29]. The PHQ-9 has been trans-
lated into local languages and previously used in both
Pakistan and India [30, 31]. The original THP trial used
diagnostic interviews for depression [22] and was found to
be effective in reducing it. In the current trials, we choose
to use PHQ-9 with a cut-off of ≥10 (i.e. moderate depres-
sion), which has good predictive value, as mentioned
above.
Inclusion criteria
Eligible participants will be pregnant women in their
second or third trimester, aged 18 years and above, who
intend to stay in the study area for at least 1 year and
score ≥10 on the PHQ-9.
Exclusion criteria
Women requiring immediate inpatient care for any reason
(medical or psychiatric) or who do not speak Urdu, Punjabi
or Potohari (Pakistan), or Konkani, Hindi or Marathi
(India) will be excluded.
Informed consent
Both trials will obtain informed written consent at screen-
ing and baseline, followed by re-affirmation of consent at
the 3- and 6-month postnatal follow-ups. Informed writ-
ten consent will be obtained by trained research teams,
who will ensure it is taken appropriately. A copy of the
information sheets and consent forms will be left with
the participants.
A record of age, depression score and reasons for re-
fusal will be maintained for those who do not consent.
Separate consent will be taken, by trained research
teams, for participation in the qualitative sub-study and
for the audio recording of intervention sessions to
monitor therapy quality. Refusals at all stages will be
documented.
Baseline assessments
Baseline assessment will entail the following informa-
tion: (i) age in years, (ii) marital status, (iii) obstetric his-
tory, (iv) educational attainment, (v) employment status,
(vi) treatment expectation, (vii) perceived social support
and (vii) incidence of domestic violence in the last
3 months.
In Pakistan, the baseline assessments will take place at
a venue of the participants’ choice –either at her own
home, the LHWs’ house called Health House, or at any
other household in the community. In India, the base-
line assessments will take place at the hospital from
which the trial participants were recruited and, immedi-
ately after they will be asked to give informed consent.
Power calculations
The power calculations for both trials are given in
Table 4 and the assumptions are given below.
SHARE Pakistan
The power calculations assume the following:
1. That 40 village clusters are randomised with a 1:1
allocation ratio, stratified within 11 union councils
(i.e. a stratified cluster randomised trial).
2. Intra-cluster correlation (ICC) of 0.07 in the
intervention arm, and 0.05 in the control arm, to
allow for between-village cluster correlation. This is
a conservative estimate based on the Rahman et al.
Table 3 Study settings
Study settings Pakistan India
Study area Kallar Syedan, one
of the seven rural
sub-districts of the
district Rawalpindi
Three out of six
sub-districts of North
Goa district: Bardez,
Bicholim and Tiswadi
talukas.
Population 170,000 1,460,000
Average household
size
6.2 members 4.2 members
Livelihood Mainly subsistence
farming, supported
by serving in the
armed forces or
working as government
employees and
semi-skilled or unskilled
labourers in the cities
Mainly tourism
supported by
mining and agriculture
Literacy rates Males 80 %, females
50 %
Males 93 %, females
82 %
Infant mortality
rates
84 per 1000 live births 9 per 1000 live births
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THP trial [22] in a similar population, where ICC of
0.04–0.09 was observed between union councils
(which were the cluster units). We would expect a
substantially lower ICC between villages within a
union council.
3. That 14 participants are recruited per village
cluster, with loss to follow-up of 20 % over
6 months (conservative, based on the Rahman
et al. trial, which had 10 % loss to follow-up of
mothers at 6 months) [22].
The sample size of 560 participants recruited provides
90 % power to detect a difference in remission at
6 months of 65 % in the intervention arm and 45 % in
the control arm. This sample size also provides 90 %
power to detect an effect size of 0.4 for the continuous
outcomes.
SHARE India
The power calculations assume the following:
1. There are 25–40 peers in the intervention arm.
2. ICC of 0.05 is based on the Rahman et al. THP trial.
This may be conservative as the CoBalT trial found
within-therapist clustering of only 0.0027 [32] and
MANAS had 0.02 [33]. We allowed for within-
therapist clustering and variations in experience,
competence and delivery of the intervention by the
therapist. Patients randomised to one therapist may
have outcomes more similar to each other than
patients randomised to a different therapist. We
based the estimate of the within-therapist ICC on
previous studies (CoBalT trial and MANAS).
3. Loss to follow-up of 15 % over 6 months (based
on the Goa postnatal depression cohort study,
Fig. 1 Flow chart: SHARE Pakistan trial
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which reported an attrition rate of 13 % over
6 months) [8].
4. Equally sized groups (1:1 allocation ratio) due to the
relatively small ICC.
5. Remission rates at 6 months of 45 % in the control
arm and 65 % in the intervention arm (based on the
Rahman et al. THP trial, which had recovery rates of
47 % and 77 % respectively; slightly lower recovery
rates are assumed as the intervention is being
delivered by peers).
Randomisation
SHARE Pakistan
Within each of the 11 union councils (of the sub-
district), village clusters will be randomised to the inter-
vention and control arms using a 1:1 allocation ratio.
Randomisation will be done before the participants are
recruited. Research teams responsible for identifying,
obtaining consent and recruiting trial participants will
be blind to the allocation status. This will help to
minimise the post-randomisation recruitment bias.
Stratification by union councils will minimise the im-
balance between arms by factors likely to be associated
with the primary outcome and reduce the between-
cluster variability, hence increasing the power of the
study. Allocation of clusters will be carried out by an
independent statistician based at the London School
of Hygiene and Tropical Medicine (LSHTM) using a
computerised randomisation sequence.
SHARE India
Treatment allocation of participants will be carried out
after informed consent is obtained and the eligible
women have completed their baseline assessments and
seen the doctor for their antenatal check-up. Stratifica-
tion by urban or rural place of residence will minimise
imbalance between arms, since pilot data indicated dif-
ferences in prevalence of depression between rural and
urban areas, hence increasing the power of the study.
Allocation will be carried out using sequentially num-
bered opaque sealed envelopes [34] prepared by an inde-
pendent statistician at LSHTM.
Fig. 2 Flow chart: SHARE India trial
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Interventions
Thinking Healthy Programme Peer-delivered
THP has been adopted by WHO for global implementa-
tion as part of the mhGAP series on low-intensity
psychological interventions [26]. The original THP was
developed and tested in Pakistan where it was delivered
by government-employed LHWs [22, 25]. THP was
adapted for peer delivery by undertaking an extensive
formative phase prior to setting up the trials. In total, 61
in-depth interviews (IDIs) and 3 focus group discussions
were conducted in Goa, and 38 IDIs and 10 focus group
discussions in Rawalpindi [27]. The formative research
findings along with the process findings from the ori-
ginal trial provided the rationale for adapting and further
simplifying the key strategies for delivery by peers. In
THPP, the focus is on identifying the mother’s unhealthy
behaviours (rather than cognitions as in the original
THP), replacing them with healthy behaviours, and prac-
tising these (focus on behavioural activation).
In Pakistan, the peers are called razakaar (meaning
‘volunteer’), while in India they are called sakhis (mean-
ing ‘friend’). In Pakistan, the peers will be working in
partnership with the community-based LHWs, who run
women’s groups. The intervention starts from the third
trimester of pregnancy until the sixth postnatal month
and includes ten home-based individual face-to-face ses-
sions and four group-based sessions (given in the LHW
women’s groups). Part of the task sharing by peers is to
assist LHWs in organising and conducting their existing
routine women’s groups and to encourage trial partici-
pants to attend these sessions. These group sessions
(within the intervention arm only) will be held at the
house of the local LHW (called a Health House). All
these women will continue to receive their local LHW’s
routine monthly care visits.
In India, the intervention sessions will start from the
second or third trimester of pregnancy until the 6-month
postnatal follow-up. The intervention will be delivered
through individual face-to-face sessions (minimum 6 and
maximum 14 sessions). The venue for session delivery,
agreed collaboratively with the trial participants, will pri-
marily be at the participants’ homes.
Peers will be lay women, without any mental health
training background who have shown an interest or de-
sire to help and support other women within their com-
munity. These peers will be from the same communities
as the trial participants or nearby communities. All the
peers will be married, mothers and fluent in the local
languages of the trial settings in Pakistan and India. All
peers will be identified and recruited from the local
community through word of mouth, particularly through
community-based key informants such as the LHWs in
Pakistan, and women’s group facilitators and anganwadi
workers (community health-care workers responsible for
the well-being and nutrition of mothers and newborn
children) in India.
The peers will be trained in a 5-day classroom-based
workshop (approximately 4–5 hours daily). This will be
followed by a 2-month internship where they can prac-
tise the content of the THPP on non-trial participants.
During this time, they will receive regular monitoring
and competency checks, and be supervised. The training
format will be based on interactive discussions and role-
playing and will cover the following topics: content of
the THPP intervention, confidentiality, dealing with dif-
ficult situations, and detection and reporting of serious
adverse events (SAEs). In Pakistan, the LHWs will be
part of the training session that covers confidentiality for
peers. This will help ensure confidentiality of the partici-
pants by both the peers and LHWs. This will be
refreshed and reiterated in monthly supervision meet-
ings. Peers will also receive training on how and when to
communicate with the research teams if any of these
situations arise, and to take the necessary steps to trigger
the referral pathway and an assessment of the trial
participant by an independent psychiatrist. Peers will be
assessed, at the end of their training, on their compe-
tence using structured and standardised role-playing.
Table 4 Power calculations: SHARE trials
Assumptions Pakistan India
Unit of randomisation Villages (stratified
within union
councils)
Individual (stratified
by urban/rural area
of residence)
Intra-cluster correlation 0.07 in the
intervention arm
0.05 in the intervention
arm (30 therapists;
within-therapist
clustering) [22, 32, 33]0.05 in the control
arm (between-village
clustering) [22]
Loss to follow-up over
6 months
20 % [22] 15 % [8]
Allocation ratio
(intervention/control)
1:1 1:1
Number of participants 560 (14 per village;
40 village clusters)
280
Outcome Power
Remission at 6 months
(PHQ-9 < 10) of 65 % in
the intervention arm vs
45 % in the control
arm [22]
90 % 86 %
Remission at 6 months
(PHQ-9≤ 5) of 38 %
in the intervention
arm vs 22 % in the
control arm [22]
81 % 74 %
Depression severity
at 6 months (PHQ-9
score) – effect size 0.4
90 % 84 %
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This will indicate any further training needs. Only peers
who achieve the desired level of competence will be se-
lected to deliver THPP in the trials.
Peers will receive monthly group-based supervision by
trained intervention facilitators (who will be part of the
research teams). The monthly supervision will include
revision of the THPP content through discussions and
role-playing. The discussions will cover the challenges
faced by peers in the field, issues around confidentiality,
detection of SAEs, problem-solving and keeping peers
motivated.
Enhanced usual care
Participants will receive EUC in both the intervention
and control arms, as there is non-existent usual care for
perinatal depression. The majority of cases of perinatal
depression either remain unidentified or are classified as
pregnancy blues in both settings. There is no provision
of services for mothers with depression in the primary
health-care system of Pakistan or in hospitals in Goa.
EUC will comprise the following:
1. Informing participants about their diagnosis of
depression.
2. Informing depressed participants about ways to seek
appropriate health care (i.e. by going for assistance
to their LHWs, to the primary health centre or to
the tertiary health centre, which is the Institute of
Psychiatry, Rawalpindi, Pakistan).
3. In India, providing gynaecologists with the findings
of the screening results for perinatal depression.
4. Providing the primary health-care centres and the
gynaecologists with the adapted WHO mhGAP
treatment guidelines for perinatal depression [35].
5. Providing an information sheet to all pregnant
women about how and where to seek health care
from including local Community Health Workers
(CHWs), primary health facilities and tertiary care
facilities, both during pregnancy and beyond.
Outcome evaluation
The primary end point of the trial is 6 months postnatal;
in addition, interim follow-up data will also be collected
at 3 months postnatal. At each follow-up, consent will
be reaffirmed by trained research assessment teams.
The outcome assessment measures with the specific
outcomes are given in Tables 1 and 2, and they are de-
scribed briefly below.
Patient health questionnaire
PHQ-9 scores the nine DSM-IV symptom-based criteria
for depression on a four-point Likert scale from not having
the symptom at all, to having it nearly every day, over the
last 2 weeks. The score for each item is summed to arrive
at a total score. The cut-off point of 10 is selected as the
most accurate value for the detection of depression [28]
and has a high positive predictive value for the diagnosis of
depressive disorder [29]. PHQ-9 has been translated into
local languages and previously used in both Pakistan and
India [30, 31].
WHO disability assessment schedule
The WHO disability assessment schedule (WHO-DAS) is
a 12-item questionnaire for measuring functional impair-
ment over the last 30 days. In addition, two items assess
the number of days the person was unable to work in
the past 30 days. It gives a total disability score, quality
adjusted life years and number of days out of work.
WHO-DAS has been validated for international use [36].
Client service receipt inventory
This questionnaire collects data on the utilisation and
costs of health care and lost productivity (including that
of caregivers). It will provide the costs of illness (both
direct and indirect). It will be used at the 3- and 6-
month follow-ups to cover costs of illness starting from
antenatal to 6 months postnatal. Client service receipt
inventory (CSRI) has been used in the study settings,
and an adapted version will be used based on an inter-
national study on perinatal depression [37].
Multidimensional scale of perceived social support
The multidimensional scale of perceived social support
is a 12-item questionnaire that measures the perceived
social support of the mother. It has three domains of
support: (1) significant other, (2) family and (3) friend. It
is a based on a Likert scale and the higher the score, the
more the perceived social support. It has been used in
the study settings [22].
Exclusive breastfeeding
This will be based on 24-hour maternal recall using the
WHO definition of exclusive breastfeeding. It has been
used in the study settings [38, 39].
Infant anthropometry
Digital scales for weight and a tape measure for height
(height mats) will be used. Z-scores for both weight for
age and height for age will be calculated. This has been
used extensively in the study settings [22, 40].
Discontinuation criterion
Trial participants will be discontinued from the study if
there is:
– Loss of baby or miscarriage
– Development of a psychotic episode
– Development of a manic episode
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Minimisation of contamination
The risk and level of contamination will be monitored at
the levels of the peers and participants. All peers will be
instructed not to share any information about the study,
and not to provide any support to other mothers in the
community, other than the ones who are assigned to the
peer for delivery of THPP. This procedure will be regu-
larly reviewed at the peers’ monthly supervision meet-
ings. For the Pakistan trial, the risk of contamination
will be minimised by the cluster design. The interven-
tion and control village clusters will be geographically
separated and the chance of intervention cluster partici-
pants regularly meeting control cluster participants will
be negligible. Apart from this, both trials also plan to
carry out a social network analysis of participants at
the 3- and 6-month postnatal follow-ups to capture if
any sizeable contamination took place and to adjust ac-
cordingly in our final analysis, using a contamination-
adjusted intention-to-treat (ITT) analysis. The extent
of social networking will be assessed at the level of the
participants so that statistical adjustments can be made
through contamination-adjusted ITT analysis (complier
average causal effect analysis) [41, 42].
Masking
Due to the nature of the intervention, it is not possible to
mask participants and peers to treatment allocation. How-
ever, outcome evaluation will be masked, as all outcome
measures will be administered by trained research assess-
ment teams (outcome assessors), who are non-residents of
the study area, independent of the intervention and
masked to treatment allocation of the participants. Fur-
thermore, participants will be instructed not to disclose to
the outcome assessors whether they are receiving the
intervention or not. During all assessments, the primary
outcome measure (PHQ-9) will always be completed first
to minimise the risk of bias in the event of unmasking
and, if it occurs, the point of unmasking will be recorded.
Sensitivity analyses will be carried out to assess the effect
of unmasking on the primary outcomes. The intervention
and outcome assessment teams will not have any interac-
tions during the trial since there will be separate locations
and administrative management. The assessment teams
will be told that they are evaluating two interventions and
that there is genuine equipoise about which one is better.
Fidelity of the intervention
Two types of indicator will be collated, in both trials, to
evaluate the fidelity of the THPP intervention, namely,
quantity and quality. Quantity indicators will include:
1. Number and duration of sessions delivered;
information will be collated from peer logbooks,
which will record basic information about the
session, such as date, time and duration of the
session
2. Number of participants who complete the treatment
and have a planned discharge
3. Number of participants who are treatment failures
or need referral to mental health specialist services
for any other reason
SHARE Pakistan
In Pakistan, the quality of sessions delivered by peers
will be assessed using a specifically designed competency
checklist based on the six key areas of THPP and the
ENACT scale (which is an 18-item assessment for
common factors in psychological treatments), includ-
ing task-sharing initiatives with non-specialists across
cultural settings [43]. Peers’ level of competency will
be assessed using this checklist, during trainings and
monthly supervision meetings with role-playing and
sessions conducted by peers in the field.
SHARE India
In India, the quality of sessions delivered by peers will be
assessed using the therapy quality scale. This is an 18-item
scale that consists of two separate subscales: treatment-
specific skills, which are specific to an intervention (e.g.,
reviews previous session, assigns homework and involves
family members), and treatment approach skills, which as-
sess common counselling skills that the counsellor uses
(e.g., using active listening, appropriate language and a
collaborative approach). This scale is based on a 20-item
therapy quality scale used to evaluate the delivery of a cul-
turally adapted depression treatment (the Healthy Activity
Programme) by lay health workers in primary health-care
centres in Goa [44], which is known to have good psycho-
metric properties [45]. For competency, the peers will be
rated on their performance in standardised role-playing
with specific checklists for each session.
All sessions will be audio recorded and 5 % of these will
be purposively selected for transcription and rated for
fidelity by psychological treatment experts. All peers and
different sessions will be covered within the 5 %. This was
not found to be acceptable to women in Pakistan during
piloting of the intervention, therefore it was not proposed
for the trial phase.
Nested qualitative study
Trial participants will be purposively selected for qualita-
tive interviews after completing the 6-month outcome
assessments. The aim of the qualitative study is to ex-
plore the trial participants’ perceptions of the interven-
tion, the quality of the care received, their satisfaction
with the peer, and the impact of their health problems
on themselves and their children. We expect 40 women
to be approached for IDIs, which will continue until data
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saturation is reached. These interviews will include trial
participants from both intervention and control arms,
women who withdraw from the trial, participants who
recover and those who remain depressed at the final
end-point assessment. Apart from the trial participants,
we will also conduct IDIs with peers and health system
personnel to take their views and perceptions about the
linkage and task-sharing aspects of the intervention. All
interviews will be audio recorded and transcribed. Ana-
lysis will be done manually using a thematic framework
approach. The qualitative team will be separate to the
intervention and outcome assessment teams.
Data management
Baseline and follow-up outcome data will be captured
electronically using tablet computers. In addition,
process data from peers will be collected. Baseline and
outcome data will be remotely uploaded as a CSV
(comma-separated values) file to the main data server,
which will run the software programs STAR and ODK
in India and Pakistan, respectively. Both files will be
compliant with good clinical practices (including a date
and time stamp of original data entry and with an audit
trail to document any subsequent changes). Process data
will be collected in paper form, and this will be manually
entered and stored as CSV files using the same data col-
lection platform. THPP quality-related data will also be
collected in paper form. All data, range and consistency
checks will be performed at weekly intervals separately
for each data source. Any queries identified will be re-
solved promptly by the data management team, and the
database will be updated, maintaining the audit trail. All
types of data will be kept in separate databases and only
merged into a master database after data collection is
completed and each individual database is locked. Ac-
cess to the data will be protected by password at mul-
tiple levels and no member of the trial team apart from
the data managers will have access to these passwords.
The database will be backed up daily, with off-site stor-
age on external hard drives and DVD media.
Qualitative data will be collected using digital re-
corders together with written field notes and memos.
The former will be transcribed in the language of the
interview, anonymised but linked with the trial ID and
translated for analysis. A similar procedure will be
followed for the written data. Digital recordings will be
stored in a secure, password-protected folder.
Analysis
The quantitative analysis will be done using STATA
(version 13) following CONSORT guidelines for individu-
ally randomised and cluster-randomised trials respectively.
Flow charts will include the number of participants seen
at each stage of the trial, including the number screened,
eligible, randomised and analysed for the primary out-
come. Initial analyses will compare baseline characteristics
of enrolled participants by arm and follow-up status. The
outcome measures will be summarised at baseline and the
3- and 6-month postnatal follow-ups by intervention arm,
summarised by means (standard deviation), medians
(interquartile range) or numbers and proportions as ap-
propriate (and including age, gender and baseline out-
come score). For continuous outcomes, histograms within
each arm will be plotted to assess how closely the scales
follow a normal distribution to determine how to describe
the outcomes and how to do the inferential analysis
properly.
The primary analyses will be ITT at the 6-month
follow-up visit adjusted for the baseline measure of the
outcome. In the Pakistan trial, mixed-effects logistic re-
gression models will be used to analyse binary outcomes,
adjusting for village clusters as random-effects variables
and Union Councils as fixed effects. In the Indian trial,
peers will be adjusted for as a random effect in the ana-
lysis. Analyses of continuous outcomes will use mixed-
effects linear regression, additionally adjusting for the
baseline value of the outcome. Adjustments will also be
made for variables for which randomisation did not
achieve a balance between the two arms at baseline.
Effect sizes will be reported as: (1) crude and adjusted
relative risks estimated using the marginal standardisation
technique with 95 % confidence intervals for the ratios es-
timated via the delta method [46] for binary outcomes, (2)
and as mean differences and standardised mean differ-
ences, with 95 % confidence intervals for continuous out-
comes. Missing data for the outcomes will be estimated
using multiple imputation [47]. Secondary analyses will in-
clude repeated measures analyses of data collected at the
3- and 6-month postnatal follow-ups, which is efficient
use of all available data.
Economic analysis
Service utilisation and the out-of-pocket expenditures of
the participants and the infants (costs for seeing a doctor
or other health-care provider, admission to hospital,
medicines, tests and extra help at home) will be col-
lected in both trials (at the 3- and 6-month postnatal
follow-ups). The data collected through the CSRI will be
used to calculate service costs and total costs of care for
each participant. Unit costs of services itemised in the
CSRI – such as cost per outpatient visit – will be based
on locally conducted health facility costing exercises.
Service cost data will subsequently be linked to primary
and secondary study outcomes, in particular depression
and disability summary scores (PHQ-9 and WHO-DAS,
respectively), to assess issues around the value or cost-
effectiveness of the task-shifting intervention. In the
event that dominance is not shown, i.e. the THPP
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intervention is more effective but the costs are also more
than in the EUC group, incremental cost-effectiveness
ratios will be computed, together with their confidence
intervals (using bootstrapping techniques to overcome
the expected skewness of the cost data). Results will be
plotted on a cost-effectiveness plane and presented as
cost-effectiveness acceptability curves to show the prob-
ability of the intervention being cost-effective at a range
of willingness-to-pay threshold levels. A sensitivity ana-
lysis will be conducted to take account of uncertainty
and imprecision in the measurements, including mul-
tiple imputation models for missing values.
Compliance analysis
A proportion of participants, in both trials, may comply
poorly with the THPP intervention. A complier average
causal effect analysis will be undertaken, which estimates
the effect of the intervention on the participants who re-
ceived it as intended by the original randomisation. This
assumes that participants in the EUC arm have the same
probability of non-compliance as do participants in the
THPP arm. We will also adjust the analysis for contam-
ination between arms (i.e. if participants in the EUC arm
were exposed to the intervention through contact with
intervention arm participants).
Moderator analysis
Moderator analyses will be used in both trials to help clar-
ify on whom and under what circumstances (moderators)
the THPP intervention works. We will assess modification
of treatment effect by a priori defined modifiers (age
group, socio-economic status, education, parity, chronicity
of depression, baseline severity of depression and patient
expectations), by fitting appropriate interaction terms and
testing for heterogeneity of treatment effects in regression
models. We will also carry out mediator analysis to see
what key behaviours our intervention activated or affected
that led to improved outcomes at 3 and 6 months. The
hypothesised mediators include behavioural activation
(assessed by the premium abbreviated activation scale),
perceived social support (assessed by the multidimen-
sional scale of perceived social support) and mother–child
attachment (assessed by items of the maternal postnatal
attachment scale).
Trial management
The progress of the trials will be monitored by three
committees. Table 5 shows the role and scope of these
committees. Trial monitoring and auditing will comprise
the collation and reporting of routine trial process indi-
cators and SAEs. Summary statistics and graphs showing
trends over time will be compiled for the process indica-
tors, and reported weekly to the trial management com-
mittee (TMC), monthly to the trial steering committee
(TSC) and twice per year to the data safety and monitor-
ing board (DSMB) in the USA.
Ethical considerations
The trial protocols have been granted ethical approval
from the respective sites, the Institutional Review Board of
Human Development Research Foundation (Pakistan),
Institutional Review Board of Sangath (Goa, India), Indian
Council of Medical Research, Observational/Interventions
Research Ethics Committee of LSHTM, UK, and the
Committee of Research Ethics at University of Liverpool,
UK. Lastly, both trial protocols have ethical approval
granted by the Global Mental Health DSMB of NIMH,
USA.
Written (or witnessed or audio recorded, if the partici-
pant is illiterate) informed consent will be mandatory for
enrolment. Separate consent will be taken for participa-
tion in the qualitative study. All participants will be able
to access EUC, which represents a higher quality of care
than what is currently available at both sites. We will
protect the confidentiality of personal data principally
through procedures to separate study data and participant-
identifiable data. Quantitative data gathered in the tablets
for each participant at baseline will retain personal identifi-
cation items to minimise errors in transcribing identities,
but these will be removed before transferring the data to
STATA for analysis. We will monitor the occurrence of a
number of specific SAEs, which include death of the par-
ticipant due to any cause, suicide attempt, violence against
the participant, stillbirth, miscarriage or loss of child, stig-
matisation (due to the intervention), any violence towards
others, in particular the participant’s children, hospital
admission due to a psychiatric problem and hospital
admission of the participant or infant due to a serious
medical emergency. Their detection, appropriate response
(involving an independent psychiatrist responding within
3 working days, if requiring immediate response) and
reporting will be governed by the standard operating pro-
cedure approved by the DSMB, which sets out the a priori
criteria for unblinding of adverse events (i.e. a statistically
significant difference in prevalence between the two arms).
SAEs will be compiled by the data manager and a blinded
summary report shared with the principal investigators,
local ethics committees and the DSMB.
Discussion
The SHARE THPP trials will provide evidence on the
effectiveness and cost-effectiveness of an empirically
supported and WHO-mandated psychological treatment
delivered by peers in an LMIC context.
There is a compelling need to address maternal mental
health [48], which is linked to poor child development
[16], increased risk of comorbidity and maternal mortal-
ity, and the existing treatment gap. The SHARE trials
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have the potential to address all of the above, that is, (i)
burden of perinatal depression, (ii) child outcomes
linked with perinatal depression and (iii) reducing the
treatment gap.
The trials, set in two very different contexts (rural and
urban), are designed to establish a partnership of an un-
tapped human resource (in the form of peers) alongside
existing health systems, have a structured training and
supervision model for peers, employ minimum exclusion
criteria for participation and include a comprehensive
economic assessment. This in turn will help the external
validity of the trial findings and provide a potential
model for scaling up in similar resource-poor settings of
LMICs as well as for well-resourced contexts (where a
mental health treatment gap exists). Overall, the trials
provide a unique opportunity for global lessons on the
mechanisms of identifying, recruiting, training and
supervising lay peers, working in partnership with the
existing health systems in two different settings.
The main limitation of our trials is that we are not
using diagnostic interviews for perinatal depression.
However, if the results are scaled up, it will be highly
unlikely that trained mental health professionals would
be diagnosing depression at the primary care level, espe-
cially in resource-poor settings.
Trial status
Both the Pakistan and India trials began recruitment of
participants in October 2014. The Pakistan trial, based
on our previous work and pilot results with an approxi-
mately 25 % rate of perinatal depression, expects to
recruit the sample within 12–15 months (by January
2016). The end-point assessments of all the participants
at the 6-month postnatal follow-up will be completed by
the end of September 2016. The Indian trial, based on
our previous work and pilot results with an approxi-
mately 8 % rate of perinatal depression, is expected to
recruit the sample within 19 months (by April 2016).
The final outcome assessments of all the participants at
the 6-month postnatal follow-up will be completed by
end of April 2017.
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Table 5 Trial management committees
Committee Role Members Frequency of
meeting
Trial management committee
(TMC)
Monitor all aspects of the conduct and progress of the trial, ensure
that the protocol is adhered to, in particular the protocol related to
the monitoring and reporting of SAEs, and take appropriate action
to safeguard participants and the quality of the trial itself.
Principal investigators Weekly
Site principal
investigators
Trial managers
Research team leads
Intervention team
leads
Data managers
Trial steering committee (TSC) Provide overall governance and oversight of the trial and ensure
that it is being conducted in accordance with the protocol and the
relevant regulations. The TSC must agree the final trial protocol and
any protocol amendments, and provide advice to the TMC on all
aspects of the trial. Decisions about termination of the trial or
substantial amendments to the protocol are the final responsibility
of the TSC. The TSC comprises the sponsors and funders, NIMH being
the funder and LSHTM and University of Liverpool being the sponsors
of SHARE India and Pakistan, respectively. Both sponsoring institutions
will be responsible for individual sites.
NIMH staff Monthly
Trial statistician and
Data Coordinating
Centre (LSHTM, UK) staff
Members of the
TMC
Data safety and monitoring
board (DSMB)
The DSMB has been set up by NIMH, USA, to work specifically with
the Global Hubs trials. The DSMB will ensure the safety of participants.
The board will review and approve the study protocols, informed
consent and all relevant documents and procedures. It is responsible
for site monitoring and audit of the progress of the study, including
recruitment and retention of participants, adverse events, SAEs and
adherence to the time line of the study, and for making recommendations
about the continuation, modification or termination of the study,
based on the balance of adverse events and beneficial outcomes.
Apart from this, the sites will submit reports twice per year with details
of data collection and adverse events.
NIMH staff Six monthly
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